Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Market Perspective (2018-2033)
2.2 Alzheimer's Disease Growth Trends by Region
2.2.1 Global Alzheimer's Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Alzheimer's Disease Historic Market Size by Region (2018-2023)
2.2.3 Alzheimer's Disease Forecasted Market Size by Region (2024-2033)
2.3 Alzheimer's Disease Market Dynamics
2.3.1 Alzheimer's Disease Industry Trends
2.3.2 Alzheimer's Disease Market Drivers
2.3.3 Alzheimer's Disease Market Challenges
2.3.4 Alzheimer's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Players by Revenue
3.1.1 Global Top Alzheimer's Disease Players by Revenue (2018-2023)
3.1.2 Global Alzheimer's Disease Revenue Market Share by Players (2018-2023)
3.2 Global Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer's Disease Revenue
3.4 Global Alzheimer's Disease Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Revenue in 2022
3.5 Alzheimer's Disease Key Players Head office and Area Served
3.6 Key Players Alzheimer's Disease Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Breakdown Data by Type
4.1 Global Alzheimer's Disease Historic Market Size by Type (2018-2023)
4.2 Global Alzheimer's Disease Forecasted Market Size by Type (2024-2033)
5 Alzheimer's Disease Breakdown Data by Application
5.1 Global Alzheimer's Disease Historic Market Size by Application (2018-2023)
5.2 Global Alzheimer's Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Alzheimer's Disease Market Size (2018-2033)
6.2 North America Alzheimer's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Alzheimer's Disease Market Size by Country (2018-2023)
6.4 North America Alzheimer's Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Market Size (2018-2033)
7.2 Europe Alzheimer's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Alzheimer's Disease Market Size by Country (2018-2023)
7.4 Europe Alzheimer's Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Market Size (2018-2033)
8.2 Asia-Pacific Alzheimer's Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Alzheimer's Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Alzheimer's Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Market Size (2018-2033)
9.2 Latin America Alzheimer's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Alzheimer's Disease Market Size by Country (2018-2023)
9.4 Latin America Alzheimer's Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Market Size (2018-2033)
10.2 Middle East & Africa Alzheimer's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Alzheimer's Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Alzheimer's Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Alzheimer's Disease Introduction
11.1.4 Allergan Revenue in Alzheimer's Disease Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer's Disease Introduction
11.2.4 Eisai Revenue in Alzheimer's Disease Business (2018-2023)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer's Disease Introduction
11.3.4 Novartis Revenue in Alzheimer's Disease Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Alzheimer's Disease Introduction
11.4.4 Daiichi Sankyo Revenue in Alzheimer's Disease Business (2018-2023)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Detail
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Alzheimer's Disease Introduction
11.5.4 Merz Pharma Revenue in Alzheimer's Disease Business (2018-2023)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Alzheimer's Disease Introduction
11.6.4 Pfizer Revenue in Alzheimer's Disease Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Alzheimer's Disease Introduction
11.7.4 Johnson & Johnson Revenue in Alzheimer's Disease Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Detail
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Alzheimer's Disease Introduction
11.8.4 Lundbeck Revenue in Alzheimer's Disease Business (2018-2023)
11.8.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Alzheimer's Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Donepezil
Table 3. Key Players of Memantine
Table 4. Key Players of Rivastigmine
Table 5. Global Alzheimer's Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Alzheimer's Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Alzheimer's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Alzheimer's Disease Market Share by Region (2018-2023)
Table 9. Global Alzheimer's Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Alzheimer's Disease Market Share by Region (2024-2033)
Table 11. Alzheimer's Disease Market Trends
Table 12. Alzheimer's Disease Market Drivers
Table 13. Alzheimer's Disease Market Challenges
Table 14. Alzheimer's Disease Market Restraints
Table 15. Global Alzheimer's Disease Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Alzheimer's Disease Market Share by Players (2018-2023)
Table 17. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2022)
Table 18. Ranking of Global Top Alzheimer's Disease Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alzheimer's Disease Product Solution and Service
Table 22. Date of Enter into Alzheimer's Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer's Disease Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Alzheimer's Disease Revenue Market Share by Type (2018-2023)
Table 26. Global Alzheimer's Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Alzheimer's Disease Revenue Market Share by Type (2024-2033)
Table 28. Global Alzheimer's Disease Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Alzheimer's Disease Revenue Market Share by Application (2018-2023)
Table 30. Global Alzheimer's Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Alzheimer's Disease Revenue Market Share by Application (2024-2033)
Table 32. North America Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Alzheimer's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Alzheimer's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Alzheimer's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Alzheimer's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Alzheimer's Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Alzheimer's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Alzheimer's Disease Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Alzheimer's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Alzheimer's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Alzheimer's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 47. Allergan Company Detail
Table 48. Allergan Business Overview
Table 49. Allergan Alzheimer's Disease Product
Table 50. Allergan Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. Eisai Company Detail
Table 53. Eisai Business Overview
Table 54. Eisai Alzheimer's Disease Product
Table 55. Eisai Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 56. Eisai Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Alzheimer's Disease Product
Table 60. Novartis Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Daiichi Sankyo Company Detail
Table 63. Daiichi Sankyo Business Overview
Table 64. Daiichi Sankyo Alzheimer's Disease Product
Table 65. Daiichi Sankyo Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 66. Daiichi Sankyo Recent Development
Table 67. Merz Pharma Company Detail
Table 68. Merz Pharma Business Overview
Table 69. Merz Pharma Alzheimer's Disease Product
Table 70. Merz Pharma Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 71. Merz Pharma Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Alzheimer's Disease Product
Table 75. Pfizer Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Johnson & Johnson Company Detail
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Alzheimer's Disease Product
Table 80. Johnson & Johnson Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Lundbeck Company Detail
Table 83. Lundbeck Business Overview
Table 84. Lundbeck Alzheimer's Disease Product
Table 85. Lundbeck Revenue in Alzheimer's Disease Business (2018-2023) & (US$ Million)
Table 86. Lundbeck Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Alzheimer's Disease Market Share by Type: 2022 VS 2033
Figure 3. Donepezil Features
Figure 4. Memantine Features
Figure 5. Rivastigmine Features
Figure 6. Global Alzheimer's Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Alzheimer's Disease Market Share by Application: 2022 VS 2033
Figure 8. Early to Moderate Stages Case Studies
Figure 9. Moderate to Severe Stages Case Studies
Figure 10. Alzheimer's Disease Report Years Considered
Figure 11. Global Alzheimer's Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Alzheimer's Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Alzheimer's Disease Market Share by Region: 2022 VS 2033
Figure 14. Global Alzheimer's Disease Market Share by Players in 2022
Figure 15. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer's Disease Revenue in 2022
Figure 17. North America Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Alzheimer's Disease Market Share by Country (2018-2033)
Figure 19. United States Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Alzheimer's Disease Market Share by Country (2018-2033)
Figure 23. Germany Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Alzheimer's Disease Market Share by Region (2018-2033)
Figure 31. China Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Alzheimer's Disease Market Share by Country (2018-2033)
Figure 39. Mexico Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Alzheimer's Disease Market Share by Country (2018-2033)
Figure 43. Turkey Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Alzheimer's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Allergan Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 46. Eisai Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 48. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 49. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 51. Johnson & Johnson Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 52. Lundbeck Revenue Growth Rate in Alzheimer's Disease Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed